Skip to main content
Clinical Trials/NL-OMON45573
NL-OMON45573
Completed
Phase 4

Esophageal HILZO Covered self-expandable metal stent for palliation of malignant dysphagia: A Safety and Feasibility Study - HILZO-study

Radboud Universitair Medisch Centrum0 sites30 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Radboud Universitair Medisch Centrum
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Non\-operable malignant obstruction of the esophagus or esophagogastric junction, extrinsic malignant compression, or recurrent malignant dysphagia after esophagectomy. A tumor is considered inoperable if the patient has local tumor infiltration in the surrounding organs, distant metastases or a poor general health due to serious concomitant disease.
  • Recurrent dysphagia after prior radiation with curative or palliative intent for esophageal or gastric cardia cancer.
  • Requiring treatment for dysphagia (dysphagia score of 2\-4, according to Ogilvie2\)
  • Written informed consent
  • Age \>\= 18 years

Exclusion Criteria

  • Inappropriate cultural level and understanding of the study.
  • Simultaneous participation in another clinical study
  • Life expectancy of less than 12 months
  • Stenosis after laryngectomy, or if the distance between the upper edge of the stent is less than 2 cm from the upper esophageal sphincter
  • Tumor length of more than 12cm
  • Coagulopathy
  • Previous stent placement for the same condition

Outcomes

Primary Outcomes

Not specified

Similar Trials